Wegovy Breakthrough: FDA Resolves Shortage, Reveals New Insights on Weight Loss and Medical Innovation cover art

Wegovy Breakthrough: FDA Resolves Shortage, Reveals New Insights on Weight Loss and Medical Innovation

Wegovy Breakthrough: FDA Resolves Shortage, Reveals New Insights on Weight Loss and Medical Innovation

Listen for free

View show details

About this listen

# Wegovy Breakthrough: FDA Shortage Resolution & New Developments | Quiet Please Podcast

Explore the latest developments in the Wegovy weight loss revolution with host Alexandra Reeves. This episode unpacks the FDA's recent resolution of Wegovy shortages, making this groundbreaking obesity medication more accessible to patients nationwide. Learn about Novo Nordisk's extended savings program reducing costs to $499/month for eligible uninsured patients—a significant drop from the $1,349 list price.

We dive into the scientific advancements with the STEP UP study revealing a high-dose Wegovy option achieving 20.7% weight loss, surpassing the standard dose. The episode also examines the growing legal challenges with over 1,500 cases now in multi-district litigation regarding potential side effects.

From its economic impact boosting Denmark's economy to its cultural significance in Hollywood and beyond, discover how Wegovy is reshaping our understanding of obesity treatment, healthcare accessibility, and pharmaceutical innovation. Subscribe to Quiet Please for ongoing coverage of this medical breakthrough that generated $9.4 billion in revenue last year alone.
activate_mytile_page_redirect_t1

What listeners say about Wegovy Breakthrough: FDA Resolves Shortage, Reveals New Insights on Weight Loss and Medical Innovation

Average Customer Ratings

Reviews - Please select the tabs below to change the source of reviews.

In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.